刘敏, 李自雄, 路卫, 李怀芳, 曹广文. 乙型肝炎病毒垂直传播的危险因素和预防策略[J]. 上海预防医学, 2016, 28(7): 464-468.
引用本文: 刘敏, 李自雄, 路卫, 李怀芳, 曹广文. 乙型肝炎病毒垂直传播的危险因素和预防策略[J]. 上海预防医学, 2016, 28(7): 464-468.
LIU Min, LI Zi-xiong, LU Wei, LI Huai-fang, CAO Guang-wen. Risk factors and prophylactic strategies of hepatitis B virus vertical transmission[J]. Shanghai Journal of Preventive Medicine, 2016, 28(7): 464-468.
Citation: LIU Min, LI Zi-xiong, LU Wei, LI Huai-fang, CAO Guang-wen. Risk factors and prophylactic strategies of hepatitis B virus vertical transmission[J]. Shanghai Journal of Preventive Medicine, 2016, 28(7): 464-468.

乙型肝炎病毒垂直传播的危险因素和预防策略

Risk factors and prophylactic strategies of hepatitis B virus vertical transmission

  • 摘要: 乙型肝炎(乙肝)病毒(HBV)慢性感染是引起我国人群肝硬化和肝细胞癌的首要危险因素,是我国现阶段面临的重大公共卫生问题之一。由于2002年我国大陆地区普种乙肝疫苗降低了HBV免疫儿童中的横向传播,而对垂直传播的作用有限,故垂直传播已经成为HBV慢性感染的最主要因素。在未进行任何药物治疗的情况下,孕妇外周血乙肝病毒e抗原(HBeAg)阳性、高病毒载量(≥ 106拷贝/mL)是发生HBV宫内感染的独立危险因素。宫内HBV感染较儿童期感染和成年HBV人群更易发生慢性HBV感染。为了减少HBV的垂直传播,需要对外周血HBeAg阳性、高HBV DNA水平的年轻孕妇在孕28周后进行核苷(酸)类似物抗病毒治疗。对于HBeAg阳性母亲所生的新生儿,除接种乙肝疫苗外,应联合注射乙肝免疫球蛋白(HBIG)治疗。

     

    Abstract: Chronic hepatitis B virus (HBV) infection is a principal risk factor for liver cirrhosis and hepatocellular carcinoma in China, representing one of the major public health problems. Horizontal transmission of HBV in vaccinated children was greatly reduced due to widespread HBV vaccination in mainland China, which had limited effects on vertical transmission. Thus, vertical transmission became one of the main causes of HBV chronic infection. High HBV load (≥ 106 copies/mL) and hepatitis B e antigen (HBeAg)-positivity in maternal peripheral blood were independent risk factors for HBV intrauterine infection. Compared to HBV infection in early childhood and in adult, intrauterine HBV infection was more prone to developing chronic infection. To decrease vertical transmission of HBV, we recommend that young pregnant women with sero-positive for HBeAg and high serum HBV DNA level should receive antiviral treatment with nucleotide analogues since the 28th gestation weeks. For newborns born to HBeAg-positive mother, hepatitis B immunoglobulin (HBIG) injection should be administrated in combination with HBV vaccination.

     

/

返回文章
返回